| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 17.445 | 20.272 | 25.359 | 36.980 | 26.196 | 52.856 | 34.200 | 28.176 | 18.421 |
| Total Income - EUR | 0 | 21.391 | 21.804 | 25.359 | 37.755 | 26.196 | 58.740 | 34.200 | 28.176 | 18.421 |
| Total Expenses - EUR | 0 | 1.661 | 10.471 | 3.596 | 3.081 | 6.533 | 1.304 | 15.764 | 15.165 | 16.776 |
| Gross Profit/Loss - EUR | 0 | 19.730 | 11.334 | 21.763 | 34.674 | 19.663 | 57.436 | 18.436 | 13.011 | 1.645 |
| Net Profit/Loss - EUR | 0 | 19.207 | 11.334 | 20.997 | 33.728 | 18.960 | 55.851 | 17.154 | 12.632 | 1.382 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Ginsan Medcom Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 847 | 9.501 | 824 | 2.865 | 2.468 | 2.113 | 1.806 | 1.597 | 1.289 | 757 |
| Current Assets | 17.647 | 28.077 | 30.127 | 31.766 | 65.220 | 36.942 | 92.234 | 30.587 | 43.430 | 20.466 |
| Inventories | 52 | 52 | 51 | 50 | 49 | 48 | 47 | 47 | 47 | 47 |
| Receivables | 31 | 19 | 737 | 2.205 | 4.292 | 1.700 | 12.344 | 1.127 | 14.947 | 19.851 |
| Cash | 17.564 | 28.006 | 29.340 | 29.512 | 60.878 | 35.194 | 79.843 | 29.413 | 28.436 | 568 |
| Shareholders Funds | 17.975 | 36.999 | 30.356 | 34.400 | 67.462 | 38.834 | 93.823 | 32.185 | 44.719 | 19.264 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 519 | 579 | 596 | 231 | 226 | 222 | 217 | 0 | 0 | 1.959 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ginsan Medcom Srl